Profile data is unavailable for this security.
About the company
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
- Revenue in USD (TTM)86.62m
- Net income in USD-8.42m
- Incorporated2019
- Employees237.00
- LocationRockwell Medical Inc30142 WIXOM ROADWIXOM 48393United StatesUSA
- Phone+1 (248) 960-9009
- Fax+1 (302) 655-5049
- Websitehttps://www.rockwellmed.com/
More ▼
Mergers & acquisitions
| Acquired company | RMTI:NAQ since announced | Transaction value |
|---|---|---|
| Evoqua Water Technologies LLC-Hemodialysis Concentrates Business | -70.27% | 16.00m |
Data delayed at least 15 minutes, as of Jun 21 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bright Green Corp | 0.00 | -11.46m | 53.34m | 5.00 | -- | 4.80 | -- | -- | -0.0631 | -0.0631 | 0.00 | 0.0584 | 0.00 | -- | -- | 0.00 | -56.05 | -- | -84.87 | -- | -- | -- | -- | -- | -- | -18,125.84 | 0.0289 | -- | -- | -- | 52.54 | -- | -- | -- |
| Eagle Pharmaceuticals Inc | 257.55m | 11.95m | 53.77m | 134.00 | 4.54 | 0.2151 | 1.65 | 0.2088 | 0.911 | 0.911 | 19.59 | 19.25 | 0.6549 | 1.55 | 2.56 | 1,922,022.00 | 3.04 | 6.37 | 4.04 | 7.98 | 69.84 | 71.86 | 4.64 | 7.85 | 1.67 | 3.55 | 0.2178 | 0.00 | 84.56 | 5.99 | 513.14 | -8.42 | -49.05 | -- |
| VolitionRX Ltd | 797.03k | -34.91m | 53.84m | 110.00 | -- | -- | -- | 67.55 | -0.4603 | -0.4603 | 0.0104 | -0.1901 | 0.0425 | -- | 6.32 | 7,245.73 | -188.25 | -111.92 | -- | -196.20 | -- | -- | -4,425.95 | -10,793.31 | -- | -173.85 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Immix Biopharma Inc | 0.00 | -18.21m | 53.89m | 14.00 | -- | 1.93 | -- | -- | -0.9263 | -0.9263 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -77.50 | -- | -90.46 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| Reneo Pharmaceuticals Inc | 0.00 | -70.71m | 54.14m | 8.00 | -- | 0.6664 | -- | -- | -2.17 | -2.17 | 0.00 | 2.43 | 0.00 | -- | -- | 0.00 | -77.06 | -- | -83.08 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -48.95 | -- | -- | -- |
| Mural Oncology PLC | 0.00 | -191.90m | 54.83m | 117.00 | -- | 0.2334 | -- | -- | -11.49 | -11.49 | 0.00 | 13.88 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
| Ovid Therapeutics Inc | 473.53k | -50.68m | 55.34m | 40.00 | -- | 0.7053 | -- | 116.86 | -0.7174 | -0.7174 | 0.0067 | 1.11 | 0.0034 | -- | -- | 11,838.25 | -36.86 | -20.78 | -39.08 | -23.27 | -- | -- | -10,701.91 | -56.16 | -- | -- | 0.00 | -- | -73.93 | -- | 3.38 | -- | -17.14 | -- |
| Incannex Healthcare Inc | -100.00bn | -100.00bn | 55.56m | -- | -- | 3.93 | -- | -- | -- | -- | -- | 0.8907 | -- | -- | -- | -- | -- | -54.94 | -- | -59.47 | -- | -- | -- | -1,033.07 | -- | -- | 0.00 | -- | 61.92 | 3.38 | -24.35 | -- | 54.12 | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 55.78m | 237.00 | -- | 2.63 | -- | 0.644 | -0.3584 | -0.3584 | 3.33 | 0.6984 | 1.90 | 13.28 | 10.12 | 365,485.20 | -18.47 | -46.29 | -27.53 | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | 1.38 | -3.54 | 0.331 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Passage Bio Inc | 0.00 | -84.44m | 56.09m | 58.00 | -- | 0.5346 | -- | -- | -1.53 | -1.53 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -47.73 | -48.56 | -52.17 | -52.09 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.02 | -- | -43.53 | -- |
| Alpha Teknova Inc | 36.85m | -36.06m | 56.34m | 210.00 | -- | 0.6757 | -- | 1.53 | -1.05 | -1.05 | 1.05 | 2.04 | 0.2815 | 2.29 | 7.89 | 175,490.50 | -27.54 | -- | -29.30 | -- | 27.36 | -- | -97.85 | -- | 3.92 | -28.23 | 0.1365 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| vTv Therapeutics Inc | 1.00m | -20.62m | 56.68m | 16.00 | -- | 2.73 | -- | 56.68 | -8.76 | -8.76 | 0.383 | 6.91 | 0.0241 | -- | 2.04 | 62,500.00 | -63.15 | -111.84 | -128.59 | -- | -- | -- | -2,621.10 | -680.94 | -- | -- | 0.00 | -- | -100.00 | -- | -5.67 | -- | -- | -- |
| Calcimedica Inc | 0.00 | -14.94m | 57.51m | 14.00 | -- | 3.33 | -- | -- | -2.64 | -2.64 | 0.00 | 1.61 | 0.00 | -- | -- | 0.00 | -48.34 | -63.99 | -66.59 | -72.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.51 | -- | -44.35 | -- |
| Enzo Biochem Inc | 33.34m | -17.55m | 57.63m | 179.00 | -- | 0.8312 | -- | 1.73 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
Data as of Jun 21 2024. Currency figures normalised to Rockwell Medical Inc's reporting currency: US Dollar USD
17.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Mar 2024 | 2.63m | 8.67% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.12m | 3.68% |
| Perkins Capital Management, Inc.as of 31 Mar 2024 | 348.68k | 1.15% |
| Richmond Brothers, Inc.as of 31 Mar 2024 | 322.25k | 1.06% |
| Geode Capital Management LLCas of 31 Mar 2024 | 288.76k | 0.95% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 175.16k | 0.58% |
| Marshall Wace LLPas of 31 Mar 2024 | 97.83k | 0.32% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 74.30k | 0.25% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 63.84k | 0.21% |
| Citadel Securities LLCas of 31 Mar 2024 | 57.00k | 0.19% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
